Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) amino]propan-2-ol
AssigneeCelgene Corporation
InventorsEric A. Fromme, Kevin J. Klopfer
Life of this patent
Estimating the term…
Abstract
Solid forms comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl] amino-1,3,5-triazin-2-yl)amino]propan-2-ol, compositions comprising the solid forms, methods of making the solid forms and methods of using the solid forms are disclosed.
Claims23
A crystalline form of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl] amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, wherein the crystalline form is characterized by an X-ray powder diffraction pattern presented in FIG. 1.
A crystalline form of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl] amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, wherein the crystalline form is characterized by an X-ray powder diffraction pattern presented in FIG. 4.
A crystalline form of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl] amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, wherein the crystalline form is characterized by an X-ray powder diffraction pattern having peaks at 2θ angles of 16.58, 18.49, and 24.32°±0.2° 2θ.
A crystalline form of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl] amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, wherein the crystalline form is characterized by an X-ray powder diffraction pattern having peaks at 2θ angles of 21.29 and 21.79°±0.2° 2θ.
Dependencies are inferred from the claim text.